Send your comments and tips to email@example.com
Beth Israel Deaconess Medical Ctr.
Boston Medical Center
Brigham and Women's Hospital
Cambridge Health Alliance
Caritas St. Elizabeth's Medical Ctr.
Children's Hospital Boston
Dana-Farber Cancer Institute
Joslin Diabetes Center
Mass. General Hospital
Mass. Health Law
New England Baptist Hospital
Short White Coat
Tufts-New England Medical Center
UMass Memorial Medical Center
University of Massachusetts
VA Medical Centers
A Healthy Blog
Running A Hospital
Nature Network Boston
SciBos - Corie Lok's blog
Nurse at small
Dr. Gwenn Is In
Healthy Children blog
Other Globe Blogs
Elizabeth Cooney is a health reporter for the Worcester Telegram & Gazette.
Boston Globe Health and Science staff:
Karen Weintraub, Deputy Health and Science Editor, and Gideon Gil, Health and Science Editor.
Short White Coat blogger Ishani Ganguli
Short White Coat blogger Jennifer Srygley
Tuesday, July 31, 2007
Today's Globe: children's health plan; allergy-free cat sales; coffee, exercise and skin cancer; medicine mistakes; Avandia
The politically charged proposal to extend health insurance to more than 3 million poor and lower-income children nationally -- one of the most ambitious domestic health proposals to come through Congress in the last decade -- unfolded yesterday in the Senate under the shadow of a formal veto threat from President Bush.
He looks like a regular cat, white, furry, playful at times, and disinterested at others. But Judy Smith of Westwood swears that her cat, Kiki, is different, and it is not just because she spent about $7,000 to buy him. Kiki, she says, is hypoallergenic, a cat that does not cause her to sniffle and sneeze. Cat geneticists and allergists aren't so sure.
Can adding a cup or two of coffee to the exercise routine increase protection from skin cancer? New research indicates that just might be the case.
Consider it the other drug problem: Millions of people do not take their medicine correctly -- or quit taking it altogether -- and the consequences can be deadly.
Avandia, once the world's top-selling diabetes pill, should remain on the market, federal advisers said yesterday, but many recommended that the drug carry stronger warnings about its heart risks.